Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, ABBR-R809, Houston, TX, 77030, USA.
Department of Pediatrics, Inova LJ Murphy Children's Hospital, Falls Church, VA, USA.
Clin Epigenetics. 2023 Oct 21;15(1):169. doi: 10.1186/s13148-023-01587-6.
Heterozygous SNVs or CNV deletions involving the FOXF1 gene, or its distant enhancer, are causative for 80-90% of cases of alveolar capillary dysplasia with misalignment of pulmonary veins. Recently, we proposed bimodal structure and parental functional dimorphism of the lung-specific FOXF1 enhancer, with Unit 1 having higher activity on the paternal chr16 and Unit 2 on the maternal chr16. Here, we describe a novel unusually sized pathogenic de novo copy-number variant deletion involving a portion of the FOXF1 enhancer on maternal chr16 that implies narrowing Unit 2 to an essential ~ 9-kb segment. Using a restrictase-based assay, we found that this enhancer segment is weakly methylated at ApT adenine, with about twice the frequency of methylation on the maternal versus paternal chr16. Our data provide further insight into the FOXF1 enhancer structure and function.
杂合性 SNV 或 CNV 缺失涉及 FOXF1 基因或其远距离增强子,是肺静脉错位的肺泡毛细血管发育不良 80-90%的病例的致病因素。最近,我们提出了肺特异性 FOXF1 增强子的双峰结构和双亲功能二态性,单元 1 在父本 chr16 上具有更高的活性,单元 2 在母本 chr16 上具有更高的活性。在这里,我们描述了一种新型的异常大小的从头致病性拷贝数变异缺失,涉及母本 chr16 上的一部分 FOXF1 增强子,这意味着将单元 2 缩小到一个必要的~9kb 片段。使用限制酶测定法,我们发现该增强子片段在 ApT 腺嘌呤处的甲基化程度较弱,母本 chr16 上的甲基化频率约为父本 chr16 的两倍。我们的数据为 FOXF1 增强子的结构和功能提供了进一步的见解。